ClinicalTrials.Veeva

Menu

PrEPARE-SCALE: Scaling up Integrated PrEP Delivery in Kenyan Maternal and Child Health Clinics

University of Washington logo

University of Washington

Status and phase

Invitation-only
Phase 4

Conditions

Hiv

Treatments

Other: Implementation strategy package

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06526507
R01MH135730 (U.S. NIH Grant/Contract)
STUDY00019007

Details and patient eligibility

About

This project aims to develop a community of practice; then test a combination of community of practice, quality improvement, and a training toolkit, to enhance implementation and clinical outcomes; and identify patterns attributes associated with successful implementation.

Full description

Aim 1: To develop and determine the impact of a Community of Practice (CoP) on stakeholder and healthcare worker engagement and knowledge of integrated pre-exposure prophylaxis (PrEP) delivery.

Aim 2: To determine the impact of a 3-component scale-up package on implementation outcomes and PrEP patient outcomes among pregnant and postpartum populations.

Aim 2a: To determine the impact of the scale-up package on PrEP implementation outcomes, including reach, service penetration, adoption (primary outcomes), and PrEP fidelity and maintenance (secondary outcomes).

Aim 2b: To determine the impact of the scale-up package on PrEP patient outcomes, including PrEP initiation and continuation.

Aim 3: To identify difference-making bundles of facility- and regional-level attributes and implementation processes that influence reach, fidelity implementation, and maintenance.

Enrollment

17,000 estimated patients

Sex

Female

Ages

15 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Health Care Workers:

  • work at a facility involved in study
  • involved in PrEP service delivery
  • >=18 years

Clients:

  • female clients seeking health services at study facilities
  • pregnant or postpartum
  • >15 years (includes emancipated minors)

Exclusion criteria

  • N/A

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

17,000 participants in 2 patient groups

Implementation strategy package
Experimental group
Description:
Package includes a Community of Practice, a quality improvement (QI) practice, and a training \& delivery toolkit.
Treatment:
Other: Implementation strategy package
Comparison
No Intervention group

Trial contacts and locations

5

Loading...

Central trial contact

Katy Sharrock, MSc; Anjuli D Wagner, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems